Cite
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
MLA
Deursen, Anna M. M.van, et al. “The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.” Clinical Infectious Diseases, vol. 67, no. 1, July 2018, pp. 42–49. EBSCOhost, https://doi.org/10.1093/cid/ciy009.
APA
Deursen, A. M. M. van, Houten, M. A. van, Webber, C., Patton, M., Scott, D., Patterson, S., Jiang, Q., Gruber, W. C., Schmoele-Thoma, B., & Grobbee, D. E. (2018). The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study. Clinical Infectious Diseases, 67(1), 42–49. https://doi.org/10.1093/cid/ciy009
Chicago
Deursen, Anna M M van, Marlies A van Houten, Chris Webber, Michael Patton, Daniel Scott, Scott Patterson, Qin Jiang, William C Gruber, Beate Schmoele-Thoma, and Diederick E Grobbee. 2018. “The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.” Clinical Infectious Diseases 67 (1): 42–49. doi:10.1093/cid/ciy009.